Navigation Links
Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009
Date:11/10/2009

presently in phase 2b clinical trial, is intended for application in arterial thrombosis applications, initially in Acute Coronary Syndrome patients undergoing Percutaneous Coronary Intervention. REG2, Regado's second product candidate, consists of a subcutaneously administered formulation of RB006 paired with the IV bolus formulation of RB007. REG2 is currently undergoing phase 1 clinical testing and is intended for use in venous thrombosis indications

ABOUT APTAMERS

RB006 is a member of a class of compounds called aptamers. Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted protein. A key unique feature of aptamers derives from the fact that they are formed from nucleic acids. As such, their pharmacologic activity can be controlled by a matched, complementary oligonucleotide active control agent (the Watson-Crick base pair complement of a fraction of the agent to be controlled), which can bind to the aptamer, removing it from its target and reversing it biologic effects.

More information can be found at http://www.regadobio.com.

SOURCE Regado Biosciences


'/>"/>
SOURCE Regado Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009
2. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
3. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
4. Regado Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2009 on September 11, 2009
5. Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009
6. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
7. Regado Biosciences Expands Medical Advisory Board
8. Regado Biosciences Establishes Medical Advisory Board
9. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
10. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
11. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... emerging field of molecular electronics could take our ... the construction of tiny circuits from molecular components. ... take on the roles currently played by comparatively-bulky ... researchers from five Japanese and Taiwanese universities has ... electronics: a molecule called picene. In a paper ...
(Date:9/16/2014)... 2014 BlueInGreen® , a ... method for delivering dissolved gases into liquids, announced ... as a manufacturer’s representative firm to its sales ... for municipal water and wastewater applications in the ... was founded in 1992 and serves Quebec and ...
(Date:9/16/2014)... Longmeadow, MA (PRWEB) September 16, 2014 ... appointment of Brian Highley as CEO of CIRTEC. ... this exciting point for the Company.” noted Brian Highley. ... operational performance while sustaining strong organic growth over the ... CIRTEC’s growth by continuing to improve and expand the ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... initiatives to position themselves for their 89th ... labeling and encoding, Pharma Packaging Solutions is ... hardware and software and new procedures. Establishing ... Good Manufacturing Practices (cGMP), Pharma Packaging Solutions ...
Breaking Biology Technology:The future face of molecular electronics 2BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2
... on iPS Technology, SAN FRANCISCO, June ... J.,David Gladstone Institutes, an independent non-profit biomedical ... and licensing,agreement to focus on applications for ... http://www.newscom.com/cgi-bin/prnh/20080616/AQM126LOGO ), iPS cells are "reprogrammed" ...
... 16 Anesiva,Inc. (Nasdaq: ANSV ) today announced ... officer and a member of the company,s board of,directors, ... McLaughlin,who resigned as chief executive officer and member of ... a consultant to the,company., "Michael is the ideal ...
... ROSH HA,AYIN, Israel, June 16 ,EnzySurge Ltd. (EnzySurge), ... management, recently announced the formation of its,Scientific Advisory ... with diversified expertise in chronic wounds.,The Company named ... Diane L.,Krasner, PhD RN, FAAN, Joseph L. Mills, ...
Cached Biology Technology:The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease 2Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors 2Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors 3EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 2EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 3EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 4
(Date:9/16/2014)... sick can take up residence in and on the ... troublesome symptom, according to new research at Washington University ... average, healthy individuals carry about five types of viruses ... BioMed Central Biology . The study is the first ... healthy people. , The research was conducted as ...
(Date:9/16/2014)... million years ago, a 10-km diameter chunk of rock hit ... of Chicxulub with the force of 100 teratons of TNT. ... the resulting megatsunami, wildfires, global earthquakes and volcanism are widely ... for the rise of the mammals. But what happened to ... study led by researchers from the University of Arizona reveals ...
(Date:9/16/2014)... (KXL) would likely increase oil sands extraction, according to ... non-profit organization Near Zero. The results are detailed in ... both supporters and opponents of the pipeline. ... to significantly higher greenhouse gas emissions, with the exact ... "This report examines three main scenarios discussed by participants ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3Keystone XL would likely raise oil sands production and greenhouse gas emissions 2
... global warming debate has focused on carbon dioxide emissions, ... lesser-known mechanism -- dirty snow -- can explain one-third ... greenhouse gases. , Snow becomes dirty when soot from ... and falls to the ground. Soot-infused snow is darker ...
... bacterium that debilitated thousands of World War I soldiers has ... on an international vacation. The woman, who has since recovered, ... infections that can occur in returning travelers. , ... a new bacterium that had never before been isolated from ...
... of nectar spurs--the long tubes leading to plants' nectar--happens ... tongue lengths of the pollinators that drink their nectar, ... of the University of California at Davis and Scott ... They were funded by the National Science Foundation (NSF). ...
Cached Biology News:Dirty snow may warm Arctic as much as greenhouse gases 2New bacterium discovered -- related to cause of trench fever 2New bacterium discovered -- related to cause of trench fever 3New bacterium discovered -- related to cause of trench fever 4Columbine flowers develop long nectar spurs in response to pollinators 2
... polystyrene beads for hydrophobic interaction chromatography. They ... organics of molecular weight less than 2,000 ... for the adsorption of nonpolar substances or ... of detergents such as Triton X-100 and ...
... Immunogen : Fusion protein ... 474-970 of human Mi-2 Formulation: ... NaCl, 0.035% sodium azide, containing ... evaluated by immunoblot on Hela ...
... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... mM NaCl, 10 mM sodium ... glycerol, pH 7.5. Recognizes the ... kinase 2 (MAPKAPK-2) protein phosphorylated ...
...
Biology Products: